Repligen Presentations & Investor Relations material

Repligen is a bioprocessing-focused life sciences company bringing over 35 years of expertise and innovation to our customers. We are inspiring advances in bioprocessing through the development and commercialization of high-value products and flexible solutions that address critical steps in the production of biological drugs, mainly monoclonal antibodies. Our manufacturing facilities are located at our Waltham, Massachusetts headquarters in the USA, and in Lund, Sweden, Weingarten, Germany and Shrewsbury, MA. We market our products globally through a direct commercial organization in the U.S., Europe and Asia, as well as through strategic partners in select markets.

repligen.com

Repligen presentations

Repligen to Acquire Metenova AB image

Repligen to Acquire Metenova AB

Repligen logo
Repligen
Investor Presentation image

Investor Presentation

Repligen logo
Repligen
40th Annual J.P. Morgan Healthcare Conference Presentation image

40th Annual J.P. Morgan Healthcare Conference Presentation

Repligen logo
Repligen
Repligen Company Presentation image

Repligen Company Presentation

Repligen logo
Repligen
Repligen Announces Agreement to Acquire ARTeSYN Biosolutions image

Repligen Announces Agreement to Acquire ARTeSYN Biosolutions

Repligen logo
Repligen
Investor Presentation image

Investor Presentation

Repligen logo
Repligen
41st Annual J.P. Morgan Healthcare Conference image

41st Annual J.P. Morgan Healthcare Conference

Repligen logo
Repligen
Investor Day 2022 Nasdaq MarketSite image

Investor Day 2022 Nasdaq MarketSite

Repligen logo
Repligen
Investor Presentation image

Investor Presentation

Repligen logo
Repligen
Investor Presentation image

Investor Presentation

Repligen logo
Repligen
Investor Presentation image

Investor Presentation

Repligen logo
Repligen
Repligen Announces Agreement to Acquire Polymem S.A image

Repligen Announces Agreement to Acquire Polymem S.A

Repligen logo
Repligen